Search for: "Hoffmann-La Roche, Inc."
Results 41 - 60
of 129
Sorted by Relevance
|
Sort by Date
23 Jul 2013, 8:43 am
Hoffmann - La Roche Inc., 541 F.3d 1115, 1122 (Fed. [read post]
29 Oct 2012, 6:41 am
” It was also used by Justice Scalia in Hoffmann-La Roche Inc. v. [read post]
2 Sep 2011, 4:27 am
Hoffmann–La Roche, Inc., 24 F.3d 463, 469 (3d Cir.1994). [read post]
7 Sep 2010, 6:10 pm
Patent and Trademark Office et. al, (Prior Art) US: District Court New Jersey: Drug label may provide evidence of intent to induce infringement even though required by the FDA: Hoffmann-La Roche Inc. v. [read post]
27 Feb 2014, 9:38 am
Cir. 2009) and In re Hoffmann-La Roche, 587 F.3d 1333 (Fed. [read post]
11 Jul 2010, 5:49 am
See Hoffmann-La Roche Inc. v. [read post]
15 Dec 2010, 2:17 am
General Coming soon: International Classification of traditional medicine by WHO (Spicy IP) Teva Pharma uses online game to promote generic substitution (Patent Baristas) Australia: APO: Success of phase 3 trials ‘obvious’ in view of phase 1 and 2: Genentec, Inc (Patentology) Brazil: Government support to impel Brazil generic market (GenericsWeb) EU: EPO Enlarged Board of Appeal decides Broccoli (G2/07) and Tomatoes (G1/08) – essentially biological breeding processes not… [read post]
12 Nov 2018, 1:12 pm
Hoffmann-La Roche Ltd. v. [read post]
18 Oct 2010, 5:51 pm
(In doing so, the Court was careful to note that it did not take into consideration the presence of the 4 court files from the related Echostarcase, "which would have remained in California but for that litigation" citing In re Hoffmann-La Roche Inc., 587 F.3d 1333,1337 (Fed. [read post]
5 Jan 2011, 2:24 pm
Thus, just as transferring thousands of pages of relevant documents to the offices of litigation counsel in Texas in order to assert that the location of those documents favored non-transfer was entitled to no weight in In re Hoffmann-La Roche Inc., 587 F.3d 1333 (Fed. [read post]
7 Mar 2016, 1:55 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences.Never too late 83 [week ending on Sunday 14 February] – Indigenous IP | Arnold J's latest judgment flags down the iconic London black cab | Life of a national/EU trade mark ... in a map | A… [read post]
23 Feb 2016, 1:53 am
Hoffmann-La Roche AG and Genentech Inc. [read post]
14 Mar 2016, 3:23 am
Hoffmann-La Roche AG and Genentech Inc. | Design v Copyright in Italy | Unitary patent and double patenting | Regeneron Pharmaceuticals Inc v Kymab Ltd & Anor | IKEA in Indonesia | Eli Lilly v Janssen Sciences. [read post]
14 Aug 2008, 7:22 pm
Hoffmann-La Roche, Ltd., 417 F.3d 1267, 1271 (D.C. [read post]
21 Jun 2012, 11:46 am
Hoffmann-La Roche Inc. on its own behalf, and on behalf of its affiliate Roche Diagnostics 33. [read post]
8 Oct 2009, 6:05 am
Hoffmann-La Roche (Patent Docs) Razadyne (Galanthamine) - US: CAFC: You can’t rely on test results that weren’t available when your patent application was filed: Janssen Pharma and Synaptech v. [read post]
10 Jun 2014, 5:44 am
See Hoffmann–La Roche, 493 U.S. at 171, 110 S.Ct. at 486–87; see also Kleiner, 751 F.2d at 1203 (class action). [read post]
15 Apr 2020, 7:42 pm
” Hoffmann–La Roche, Inc. v. [read post]
14 Jan 2021, 8:47 am
A little history: in 1989, in the seminal Hoffmann-La Roche, Inc. v. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
